7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Hyperostosis D015576 1 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
HIV Infections D015658 20 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Fractures, Stress D015775 2 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Bacteremia D016470 9 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
POEMS Syndrome D016878 1 associated lipids
Carotid Stenosis D016893 15 associated lipids
Arthritis, Reactive D016918 3 associated lipids
beta-Thalassemia D017086 5 associated lipids
Myocardial Ischemia D017202 11 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Microvascular Angina D017566 2 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Diabetic Foot D017719 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Foot Injuries D018409 1 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Arthralgia D018771 8 associated lipids
Sepsis D018805 11 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Hot Flashes D019584 5 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Venous Thrombosis D020246 11 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Lithiasis D020347 2 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Brain Infarction D020520 17 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Spondylarthritis D025241 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Hearing Loss D034381 3 associated lipids
Mastocytoma D034801 3 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Malnutrition D044342 6 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Diabetes Complications D048909 4 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Fractures, Bone D050723 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Hypercalciuria D053565 4 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Osteophyte D054850 2 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Peri-Implantitis D057873 1 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Angina, Stable D060050 2 associated lipids
Vascular Calcification D061205 1 associated lipids
Atrial Remodeling D064752 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Stuss M et al. Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2016 Endokrynol Pol pmid:26884284
Gluba-Brzózka A et al. Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. 2016 Lipids Health Dis pmid:26843213
Melchiorre D et al. Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A. 2016 Haematologica pmid:26494839
Shimazaki E et al. TGF-β and Physiological Root Resorption of Deciduous Teeth. 2016 Int J Mol Sci pmid:28035998
Bolamperti S et al. Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. 2016 Biomed Res Int pmid:27999816
Li Y et al. Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. 2016 J. Genet. pmid:27994198
Gómez-Vaquero C et al. Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. 2016 PLoS ONE pmid:27911913
Li Y et al. OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. 2016 Medicine (Baltimore) pmid:27336899
Dolan EB et al. Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. 2016 J R Soc Interface pmid:27335224
Kassem A et al. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. 2016 PLoS ONE pmid:27311019
Wang JH et al. Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. 2016 Medicine (Baltimore) pmid:27310953
Yu M et al. Chemotherapy effectively suppresses interleukin-20, receptor activator of nuclear factor kappa-B ligand, and osteoprotegerin levels in patients with lung adenocarcinoma and bone metastasis. 2016 Apr-Jun J Cancer Res Ther pmid:27461682
Middleton K et al. Microfluidic co-culture platform for investigating osteocyte-osteoclast signalling during fluid shear stress mechanostimulation. 2017 J Biomech pmid:28552413
Jung YJ et al. Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. 2017 Mol Oral Microbiol pmid:27484636
Lu LY et al. Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway. 2017 J. Orthop. Res. pmid:28248001
Kuroyanagi G et al. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2017 Prostaglandins Other Lipid Mediat. pmid:28163121
Liu XY et al. Protective effects of total flavonoids of Astragalus against adjuvant-induced arthritis in rats by regulating OPG/RANKL/NF-κB pathway. 2017 Int. Immunopharmacol. pmid:28092862
Choi EM et al. Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. 2017 Environ. Toxicol. pmid:28836330
Chen X et al. Emodin suppresses cadmium-induced osteoporosis by inhibiting osteoclast formation. 2017 Environ. Toxicol. Pharmacol. pmid:28738286
Ozaki Y et al. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. 2017 PLoS ONE pmid:28937990
Tschiderer L et al. Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. 2017 PLoS ONE pmid:28837646
Åšliwicka E et al. Serum irisin and myostatin levels after 2 weeks of high-altitude climbing. 2017 PLoS ONE pmid:28732027
Bergdolt S et al. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing. 2017 PLoS ONE pmid:28614388
Spirlandeli AL et al. Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. 2017 Clinics (Sao Paulo) pmid:28492723
Liu J et al. MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification. 2017 PLoS ONE pmid:28319142
Songia P et al. Identification of Patients Affected by Mitral Valve Prolapse with Severe Regurgitation: A Multivariable Regression Model. 2017 Oxid Med Cell Longev pmid:28261377
Jia J et al. Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. 2017 Mol Med Rep pmid:28260003
Shetelig C et al. Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function. 2017 PLoS ONE pmid:28253327
Irtyuga O et al. NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL. 2017 Biomed Res Int pmid:28246602
Hanmoto T et al. Effects of low-intensity pulsed ultrasound on osteoclasts: Analysis with goldfish scales as a model of bone. 2017 Biomed. Res. pmid:28239034
Fioramonti M et al. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. 2017 Oncotarget pmid:28223547
Xiong L et al. Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A2AR signaling. 2017 J. Cell Biol. pmid:28193701
Fortner RT et al. Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. 2017 BMC Med pmid:28173834
Chung ST et al. Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. 2017 Mol. Cancer pmid:28143606
Yin LL et al. Relationship between the gene polymorphism of osteoprotegerin and bone mineral density in hemodialysis patients. 2017 Eur Rev Med Pharmacol Sci pmid:28121359
Bondar C et al. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease. 2017 Int J Mol Sci pmid:28098793
Shu R et al. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. 2017 PLoS ONE pmid:28081119
Ji J et al. Pathway of 3-MCPD-induced apoptosis in human embryonic kidney cells. 2017 J Toxicol Sci pmid:28070108
Sponder M et al. Endurance training significantly increases serum endocan but not osteoprotegerin levels: a prospective observational study. 2017 BMC Cardiovasc Disord pmid:28056805
Hygum K et al. MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. 2017 Eur. J. Endocrinol. pmid:28049653
Dawson S and Lawrie A From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. 2017 Pharmacol. Ther. pmid:27373854

Table of Content